Keywords: Allergan, Merz Pharma, Botox, Trade secrets, Law suit, USA, Germany, Spain, Xeomin

US court rules in favor of Allergan in Merz Botox law suit

Article | 13 March 2012

Print This

US drugmaker Allergan (NYSE: AGN) revealed that US District Judge Andrew. Guilford, after conducting a full trial, ruled that Merz ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in